Carisma Therapeutics, Inc.

Q2 2024 13F Holders

Symbol
CARM
CUSIP
14216R101
Type
Equity
Class
COM
Num filers
55
Total reported value, excl. options
$7.38M
Manager Report Date Value ($000) Shares Option Type